MRNA vs SCNI
Moderna, Inc. - Common Stock · Scinai Immunotherapeutics Ltd. - American Depositary Shares
Relative return (rebased to 100)
Key stats
| Metric | MRNA | SCNI |
|---|---|---|
| Price | $145.13 | $3.22 |
| Market Cap | $57.59B | $44.67B |
| P/E | — | — |
| P/B | 7.77 | 5512.86 |
| P/S | 29.62 | 34073.79 |
| ROE | -38.1% | -102.5% |
| Net Margin | -145.2% | -633.6% |
| Gross Margin | — | -202.3% |
| Revenue Growth | -39.9% | 99.2% |
| Dividend Yield | — | — |
| EPS | -$7.11 | -$0.00 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.